Davita Inc vs Devon Energy Corp — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while Devon Energy Corp trades at $48.79 (market cap $53.81B). The key difference: Devon Energy Corp is far larger — about 4.8× Davita Inc's market cap, and Devon Energy Corp pays a 2.62% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Devon Energy Corp for 136 Days on average.
| DVA | DVN | |
|---|---|---|
Market Cap | $11.29B | $53.81B |
Volume | 582,204 | 11,556,740 |
Sector | Health | Energy |
52-Week High | $240.96 | $52.07 |
52-Week Low | $103.87 | $31.74 |
Typical Hold Time | 113 Days | 136 Days |
Enterprise Value | $24.01B | $64.55B |
Dividend Yield | — | 2.62% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
Devon Energy (DVN) trades at $47.88, down 0.29% with a bullish technical signal from moving averages. The company shows solid fundamentals with a P/E of 10.41 and net margin of 16.67%, though revenue declined from $19.2B in 2022 to $17.2B in 2025. Recent news highlights activist investor pressure for strategic alternatives and potential asset sales, while analyst consensus remains strongly bullish with a $62.40 price target representing 30% upside.
DVN presents a compelling value opportunity with attractive valuation metrics and strong cash flow generation. However, investors face risks from oil price volatility, execution challenges in asset sales, and competitive pressures in the shale sector. The company's Permian Basin focus and potential strategic moves provide catalysts, but macroeconomic headwinds could impact near-term performance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →